Aletho News


100s of Published Reports of Post-Vaccine Medical Distress (Part 1)

By Donna Laframboise | No Fracking Consensus | January 17, 2022

COVID-19 vaccines are harming people. This fact is now extensively documented in the peer-reviewed medical literature.

We’re told these events are rare. So what’s the magic number? How many reports of alarming medical outcomes are necessary before we admit the ‘cure’ might be worse than the disease?

Most people who contract COVID don’t develop serious medical issues. But the small percentage who do can overwhelm the health care system.

Most people who receive a COVID vaccine don’t develop serious medical issues. But the small percentage who do can also overwhelm the health care system. Everyone wants to talk about the first problem. No one wants to talk about the second.

Last week, an extensive list of articles from the peer-reviewed medical literature was posted on Reddit by someone known only as xxyiorgos. More than 400 articles are on that list (backup link here).

Here are the first 100. I’ve numbered, and verified them. In some cases, I’ve updated the hyperlink. This research is emerging from numerous countries including Belgium, Canada, Germany, Greece, Italy, Norway, Qatar, South Korea, Spain, the UK, and the US.

Comments in brackets added by me.

1. Cerebral venous thrombosis after COVID-19 vaccination in the UK: a multicentre cohort study [stroke, Lancet, Aug. 2021]

2.  Vaccine-induced immune thrombotic thrombocytopenia with disseminated intravascular coagulation and death after ChAdOx1 nCoV-19 vaccination: [fatal blood clots, Journal of Stroke and Cerebrovascular Diseases, Sept. 2021]

3. Fatal cerebral hemorrhage after COVID-19 vaccine: [fatal brain bleed, Journal of the Norwegian Medical Association, Apr. 2021]

4. “Myocarditis after mRNA vaccination against SARS-CoV-2, a case series:” [heart inflammation, American Heart Journal Plus: Cardiology Research & Practice, Aug. 2021]

5. Three cases of acute venous thromboembolism in women after vaccination against COVID-19: [blood clots, Journal of Vascular Surgery: Venous and Lymphatic Disorders, Jan. 2022]

6. Acute coronary tree thrombosis after vaccination against COVID-19: [blood clots, Journal of the American College of Cardiology: Cardiovascular Interventions, May 2021]

7. US case reports of cerebral venous sinus thrombosis with thrombocytopenia after Ad26.COV2.S vaccination, March 2 to April 21, 2020: [stroke, Journal of the American Medical Association, June 2021]

8. Portal vein thrombosis associated with ChAdOx1 nCov-19 vaccine: [blood clots, Lancet, June 2021]

9. Management of cerebral and splanchnic vein thrombosis associated with thrombocytopenia in subjects previously vaccinated with Vaxzevria (AstraZeneca): position statement of the Italian Society for the Study of Hemostasis and Thrombosis (SISET): [blood clots, Blood Transfusion, July-Aug. 201]

10. Vaccine-induced immune immune thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with COVID-19; a systematic review: [blood clots, Journal of the Neurological Sciences, Sept. 2021]

11. Thrombosis with thrombocytopenia syndrome associated with COVID-19 vaccines: [blood clots, American Journal of Emergency Medicine, Nov. 2021]

12. Covid-19 vaccine-induced thrombosis and thrombocytopenia: a commentary on an important and practical clinical dilemma: [blood clots, Progress in Cardiovascular Diseases, July-Aug. 2021]

13. Thrombosis with thrombocytopenia syndrome associated with COVID-19 viral vector vaccines: [blood clots, European Journal of Internal Medicine, July 2021]

14. COVID-19 vaccine-induced immune thrombotic thrombocytopenia: an emerging cause of splanchnic vein thrombosis: [blood clots, Annals of Hepatology, July-Aug. 2021]

15. The roles of platelets in COVID-19-associated coagulopathy and vaccine-induced immune thrombotic immune thrombocytopenia (covid): [blood clots, Trends in Cardiovascular Medicine, Jan. 2022]

16. Roots of autoimmunity of thrombotic events after COVID-19 vaccination: [blood clots, Autoimmunity Reviews, Nov. 2021]

17. Cerebral venous sinus thrombosis after vaccination: the United Kingdom experience: [brain blood clots, [stroke, Lancet, Sept. 2021]

18. Thrombotic immune thrombocytopenia induced by SARS-CoV-2 vaccine: [blood clots, New England Journal of Medicine, Apr. 2021]

19. Myocarditis after immunization with COVID-19 mRNA vaccines in members of the US military: [heart inflammation, Journal of the American Medical Association, June 2021]

20. Thrombosis and thrombocytopenia after vaccination with ChAdOx1 nCoV-19: [blood clots, New England Journal of Medicine, Apr. 2021]

21. Association of myocarditis with the BNT162b2 messenger RNA COVID-19 vaccine in a case series of children: [heart inflammation, Journal of the American Medical Association Cardiology, Aug. 2021]

22. Thrombotic thrombocytopenia after vaccination with ChAdOx1 nCov-19: [blood clots, New England Journal of Medicine, June 2021]

23. Post-mortem findings in vaccine-induced thrombotic thrombocytopenia (covid-19): [fatal blood clots, Haematologica, Aug. 2021]

24. Thrombocytopenia, including immune thrombocytopenia after receiving COVID-19 mRNA vaccines reported to the Vaccine Adverse Event Reporting System (VAERS): [blood clots, Vaccine, June 2021]

25. Acute symptomatic myocarditis in seven adolescents after Pfizer-BioNTech COVID-19 vaccination: [heart inflammation, Pediatrics, Sept. 2021]

26. Aphasia seven days after the second dose of an mRNA-based SARS-CoV-2 vaccine. [brain bleed, Brain Hemorrhages, Dec. 2021]

27. Comparison of vaccine-induced thrombotic episodes between ChAdOx1 nCoV-19 and Ad26.COV.2.S vaccines: [blood clots, Journal of Autoimmunity, Aug. 2021]

28. Hypothesis behind the very rare cases of thrombosis with thrombocytopenia syndrome after SARS-CoV-2 vaccination: [blood clots, Thrombosis Research, July 2021]

29. Blood clots and bleeding episodes after BNT162b2 and ChAdOx1 nCoV-19 vaccination: analysis of European data: [blood clots, Journal of Autoimmunity, Aug. 2021]

30. Cerebral venous thrombosis after BNT162b2 mRNA SARS-CoV-2 vaccine: [stroke, Journal of Stroke and Cerebrovascular Diseases, Aug. 2021]

31. Primary adrenal insufficiency associated with thrombotic immune thrombocytopenia induced by the Oxford-AstraZeneca ChAdOx1 nCoV-19 vaccine (VITT): [blood clots, European Journal of Internal Medicine, Sept. 2021]

32. Myocarditis and pericarditis after vaccination with COVID-19 mRNA: practical considerations for care providers: [heart inflammation, Canadian Journal of Cardiology, Oct. 2021]

33. “Portal vein thrombosis occurring after the first dose of SARS-CoV-2 mRNA vaccine in a patient with antiphospholipid syndrome”: [blood clots, Thrombosis Update, Dec. 2021]

34. Early results of bivalirudin treatment for thrombotic thrombocytopenia and cerebral venous sinus thrombosis after vaccination with Ad26.COV2.S: [blood clots, Annals of Emergency Medicine, Oct. 2021]

35. Myocarditis, pericarditis and cardiomyopathy after COVID-19 vaccination: [heart inflammation, Heart, Lung and Circulation, Oct. 2021]

36. Mechanisms of immunothrombosis in vaccine-induced thrombotic thrombocytopenia (VITT) compared to natural SARS-CoV-2 infection: [blood clots, Journal of Autoimmunity, July 2021]

37. Prothrombotic immune thrombocytopenia after COVID-19 vaccination: [blood clots, Blood, July 2021]

38. Vaccine-induced thrombotic thrombocytopenia: the dark chapter of a success story: [blood clots, Metabolism Open, Sept. 2021]

39Anti-PF4 antibody negative cerebral venous sinus thrombosis without thrombocytopenia following immunization with COVID-19 vaccine in an elderly non-comorbid Indian male, managed with conventional heparin-warfarin based anticoagulation: [stroke, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, July-Aug. 2021]

40. Thrombosis after COVID-19 vaccination: possible link to ACE pathways: [blood clots, Thrombosis Research, Oct. 2021]

41. Cerebral venous sinus thrombosis in the U.S. population after SARS-CoV-2 vaccination with adenovirus and after COVID-19: [stroke, Journal of the American College of Cardiology, July 2021]

42. Middle-age Asian male with cerebral venous thrombosis after COVID-19 AstraZeneca vaccination: [stroke, American Journal of Emergency Medicine, Jan. 2022]

43. Cerebral venous sinus thrombosis and thrombocytopenia after COVID-19 vaccination: report of two cases in the United Kingdom: [stroke, Brain, Behavior, and Immunity, July 2021]

44. Immune thrombocytopenic purpura after vaccination with COVID-19 vaccine (ChAdOx1 nCov-19): [blood clots, Blood, Sept. 2021]

45. Antiphospholipid antibodies and risk of thrombophilia after COVID-19 vaccination: the straw that breaks the camel’s back?: [blood clots, Cytokine & Growth Factor Reviews, Aug. 2021]

46. Vaccine-induced thrombotic thrombocytopenia, a rare but severe case of friendly fire in the battle against the COVID-19 pandemic: What pathogenesis? [blood clots, European Journal of Internal Medicine, Sept. 2021]

47. Diagnostic-therapeutic recommendations of the ad-hoc FACME expert working group on the management of cerebral venous thrombosis related to COVID-19 vaccination: [stroke, Neurología, Spanish Neurology Society, July-Aug. 2021]

48. Thrombocytopenia and intracranial venous sinus thrombosis after exposure to the “AstraZeneca COVID-19 vaccine Astrazeneca” exposure: [stroke, Journal of Clinical Medicine, Apr. 2021]

49. Thrombocytopenia following Pfizer and Moderna SARS-CoV-2 vaccination: [blood clots, American Journal of Hematology, Feb. 2021]

50. Severe and refractory immune thrombocytopenia occurring after SARS-CoV-2 vaccination: [blood clots, Journal of Blood Medicine, Feb. 2021]

51. Purpuric rash and thrombocytopenia after mRNA-1273 (Modern) COVID-19 vaccine: [blood clots, Cureus, Mar. 2021]

52. COVID-19 vaccination: information on the occurrence of arterial and venous thrombosis using data from VigiBase: [stroke, European Respiratory Journal, July 2021]

53. Cerebral venous thrombosis associated with the covid-19 vaccine in Germany: [stroke, Annals of Neurology, July 2021]

54. Cerebral venous thrombosis following BNT162b2 mRNA vaccination of BNT162b2 against SARS-CoV-2: a black swan event: [stroke, American Journal of Hematology, June 2021]

55. The importance of recognizing cerebral venous thrombosis following anti-COVID-19 vaccination: [stroke, European Journal of Internal Medicine, May 2021]

56. Thrombosis with thrombocytopenia after messenger RNA vaccine -1273: [blood clots, Annals of Internal Medicine, Oct. 2021]

57. Blood clots and bleeding after BNT162b2 and ChAdOx1 nCoV-19 vaccination: an analysis of European data: [blood clots, Journal of Autoimmunity, Aug. 2021]

58. First dose of ChAdOx1 and BNT162b2 COVID-19 vaccines and thrombocytopenic, thromboembolic, and hemorrhagic events in Scotland: [blood clots, Nature Medicine, June 2021]

59. Exacerbation of immune thrombocytopenia after COVID-19 vaccination: [blood clots, British Journal of Haematology, June 2021]

60. First report of a de novo iTTP episode associated with a COVID-19 mRNA-based anti-COVID-19 vaccine: [blood clots, Journal of Thrombosis and Haemostasis, June 2021]

61. PF4 immunoassays in vaccine-induced thrombotic thrombocytopenia: [blood clots, New England Journal of Medicine, July 2021]

62. Antibody epitopes in vaccine-induced immune immune thrombotic thrombocytopenia: [blood clots, Nature, July 2021]

63. Myocarditis with COVID-19 mRNA vaccines: [heart inflammation, Circulation, July 2021]

64. Myocarditis and pericarditis after COVID-19 vaccination: [heart inflammation, Journal of the American Medical Association, Aug. 2021]

65. Myocarditis temporally associated with COVID-19 vaccination: [heart inflammation, Circulation, June 2021]

66. COVID-19 Vaccination Associated with Myocarditis in Adolescents: [heart inflammation, Pediatrics, Nov. 2021]

67. Acute myocarditis after administration of BNT162b2 vaccine against COVID-19: [heart inflammation, Revista Española de Cardiología, Spanish Society of Cardiology, Sept. 2021]

68. Temporal association between COVID-19 vaccine Ad26.COV2.S and acute myocarditis: case report and review of the literature: [heart inflammation, Cardiovascular Revascularization Medicine, Aug. 2021]

69. COVID-19 vaccine-induced myocarditis: a case report with review of the literature: [heart inflammation, Diabetes & Metabolic Syndrome: Clinical Research & Reviews, Sept.-Oct. 2021]

70. Potential association between COVID-19 vaccine and myocarditis: clinical and CMR findings: [heart inflammation, Journal of the American College of Cardiology: Cardiovascular Imaging, Sept. 2021]

71. Recurrence of acute myocarditis temporally associated with receipt of coronavirus mRNA disease vaccine 2019 (COVID-19) in a male adolescent: [heart inflammation, Journal of Pediatrics, Nov. 2021]

72. Fulminant myocarditis and systemic hyper inflammation temporally associated with BNT162b2 COVID-19 mRNA vaccination in two patients: [heart inflammation, International Journal of Cardiology, Oct. 2021]

73. Acute myocarditis after administration of BNT162b2 vaccine: [heart inflammation, Infectious Disease Cases, 2021]

74. Lymphohistocytic myocarditis after vaccination with COVID-19 Ad26.COV2.S viral vector: [heart inflammation, International Journal of Cardiology: Heart & Vasculature, Oct. 2021]

75. Myocarditis following vaccination with BNT162b2 in a healthy male: [heart inflammation, American Journal of Emergency Medicine, Dec. 2021]

76. Acute myocarditis after Comirnaty (Pfizer) vaccination in a healthy male with previous SARS-CoV-2 infection: [heart inflammation, Radiology Case Reports, Nov. 2021]

77. Myopericarditis after Pfizer mRNA COVID-19 vaccination in adolescents: [heart inflammation, Journal of Pediatrics, Nov. 2021]

78. Pericarditis after administration of BNT162b2 mRNA COVID-19 mRNA vaccine: [heart inflammation, Revista Española de Cardiología, Spanish Society of Cardiology, Dec. 2021]

79. Acute myocarditis after vaccination with SARS-CoV-2 mRNA-1273 mRNA: [heart inflammation, Canadian Journal of Cardiology: Open, Nov. 2021]

80. Temporal relationship between the second dose of BNT162b2 mRNA Covid-19 vaccine and cardiac involvement in a patient with previous SARS-COV-2 infection: [heart problems, International Journal of Cardiology: Heart & Vasculature, June 2021]

81. Myopericarditis after vaccination with COVID-19 mRNA in adolescents 12 to 18 years of age: [heart inflammation, Journal of Pediatrics, Nov. 2021]

82. Acute myocarditis after SARS-CoV-2 vaccination in a 24-year-old man: [heart inflammation, Portuguese Journal of Cardiology, July 2021]

83. Important information on myopericarditis after vaccination with Pfizer COVID-19 mRNA in adolescents: [heart inflammation, Journal of Pediatrics, Nov. 2021]

84. A series of patients with myocarditis after vaccination against SARS-CoV-2 with mRNA-1279 and BNT162b2: [heart inflammation, Journal of the American College of Cardiology: Cardiovascular Imaging, Sept. 2021]

85. Takotsubo cardiomyopathy after vaccination with mRNA COVID-19: [heart problems, Heart, Lung and Circulation, Dec. 2021]

86. COVID-19 mRNA vaccination and myocarditis: [heart inflammation, European Journal of Case Reports in Internal Medicine, June 2021]

87. COVID-19 vaccine and myocarditis: [heart inflammation, American Journal of Cardiology, July 2021]

88. Allergic reactions after COVID-19 vaccination: putting the risk in perspective: [allergic reactions, JAMA Network Open, Aug. 2021]

89. Anaphylactic reactions to COVID-19 mRNA vaccines: a call for further studies: [allergic reactions, Vaccine, May 2021]

90. Risk of severe allergic reactions to COVID-19 vaccines among patients with allergic skin disease: practical recommendations. An ETFAD position statement with external experts: [allergic reactions, Journal of the European Academy of Dermatology and Venereology, June 2021]

91. COVID-19 vaccine and death: causality algorithm according to the WHO eligibility diagnosis: [fatal blood clots, Diagnostics, May 2021]

92. Fatal brain hemorrhage after COVID-19 vaccine: [fatal brain bleed, Journal of the Norwegian Medical Association, April 2021]

93. A case series of skin reactions to COVID-19 vaccine in the Department of Dermatology at Loma Linda University: [skin problems, Journal of the American Academy of Dermatology: Case Reports, Aug. 2021]

94. Skin reactions reported after Moderna and Pfizer’s COVID-19 vaccination: a study based on a registry of 414 cases: [skin problems, Journal of the American Academy of Dermatology, Apr. 2021]

95. Clinical and pathologic correlates of skin reactions to COVID-19 vaccine, including V-REPP: a registry-based study: [skin problems, Journal of the American Academy of Dermatology, Sept. 2021]

96. Skin reactions after vaccination against SARS-COV-2: a nationwide Spanish cross-sectional study of 405 cases: [skin problems, British Journal of Dermatology, July 2021]

97. Varicella zoster virus and herpes simplex virus reactivation after vaccination with COVID-19: review of 40 cases in an international dermatologic registry: [herpes, Journal of the European Academy of Dermatology and Venereology, Sept. 2021]

98. Immune thrombosis and thrombocytopenia (VITT) associated with the COVID-19 vaccine: diagnostic and therapeutic recommendations for a new syndrome: [blood clots, European Journal of Haematology, May 2021]

99. Laboratory testing for suspicion of COVID-19 vaccine-induced thrombotic (immune) thrombocytopenia: [blood clots, International Journal of Laboratory Hematology, June 2021]

100. Intracerebral hemorrhage due to thrombosis with thrombocytopenia syndrome after COVID-19 vaccination: the first fatal case in Korea: [brain bleed, Journal of Korean Medical Science, Aug. 2021]

January 24, 2022 - Posted by | Science and Pseudo-Science |

1 Comment »

  1. YOU are the dis€a$e and their covaid$ death squirt the cure for your squandered pension plans.

    So simple even sheep should get it.

    covaid$ deaths…by country before and after the death shot

    2 minute global cull

    Another sheep in the mall


    Comment by planetsheeple | January 25, 2022 | Reply

Leave a Reply

Fill in your details below or click an icon to log in: Logo

You are commenting using your account. Log Out /  Change )

Twitter picture

You are commenting using your Twitter account. Log Out /  Change )

Facebook photo

You are commenting using your Facebook account. Log Out /  Change )

Connecting to %s

This site uses Akismet to reduce spam. Learn how your comment data is processed.